Evidence map›Paper›PMID 17470720›Full record

ReviewHypertension (Dallas, Tex. : 1979)2007

Personalized medicine for high blood pressure.

Stephen T Turner, Gary L Schwartz, Eric Boerwinkle

Abstract readEditorialHistorical ArticleReview
In one paragraph

Review in Hypertension (Dallas, Tex. : 1979), 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Personalized vascular medicine: individualizing drug therapy.Vascular medicine (London, England) · 2011
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Stephen T Turner
Gary L Schwartz
Eric Boerwinkle

Funding

Pharmacogenomic Evaluation of Antihypertensive ResponsesU01GM074492 · NIGMS · UNIVERSITY OF FLORIDA · PI JOHNSON, JULIE A. · 2005 to 2014
$20.7M
GENETIC EPIDEMIOLOGY OF RESPONSES TO ANTIHYPERTENSIVESR01HL053330 · NHLBI · MAYO CLINIC ROCHESTER · PI TURNER, STEPHEN T · 1997 to 2006
$5.5M
Anthipertensive PharmacoGenomicsR01HL074735 · NHLBI · MAYO CLINIC ROCHESTER · PI TURNER, STEPHEN T · 2003 to 2006
$3.4M
NHLBI NIH HHS HL 53330NHLBI NIH HHS HL 74735NHLBI NIH HHS R01 HL053330NHLBI NIH HHS R01 HL074735NIGMS NIH HHS GM 74492NIGMS NIH HHS U01 GM074492
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Patient-Centered CareCardiologyGenetic Predisposition to DiseaseHistory, 20th CenturyHumansHypertensionRisk Factors

Identifiers

PMID17470720
PMCPMC5012173

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.